Kato, M., Nishikawa, S., Ikehata, A., Dochi, K., Tani, T., Takahashi, T., & Tsuda, T
Eli Lilly and Company Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes
GLP-1 agonists work by mimicking a naturally occurring hormone that regulates blood glucose levels, enhances insulin secretion when blood sugar is elevated, suppresses glucagon release, and slows gastric emptying
G., Contreras, V., Menini, T., & Gugliucci, A
Looking for GLP-1 medications to support your weight loss journey, but want a more affordable option
What You Should Know: Noom, a digital healthcare company, is shaking up the weight loss industry with the launch of Noom GLP-1Rx, an innovative program offers affordable, accessible, and sustainable weight loss by combining compounded GLP-1 injections with Nooms proven behavioral change program